MEA castrate resistant prostate cancer market statistics, by country, 2016-2027 (USD Million)
MEA castrate-resistant prostate cancer market size was valued at 93.4 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 10.9% from 2018 to 2027.